Literature DB >> 12069996

Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.

Jean-Didier Cavallo1, Francoise Ramisse, Monique Girardet, Josée Vaissaire, Michelle Mock, Eric Hernandez.   

Abstract

Ninety-six isolates of Bacillus anthracis recovered in France between 1994 and 2000 were tested for their susceptibilities to 25 different antibiotics. Resistance to penicillin G and amoxicillin was 11.5%. All of the isolates were resistant to cotrimoxazole and susceptible to doxycycline, ciprofloxacin, pefloxacin, levofloxacin, teicoplanin, vancomycin, clindamycin, imipenem, and rifampin.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12069996      PMCID： PMC127281          DOI： 10.1128/AAC.46.7.2307-2309.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne.

Authors:  C H Choe; S S Bouhaouala; I Brook; T B Elliot; G B Knudson
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Antimicrobial susceptibility of Bacillus anthracis.

Authors:  M Doğanay; N Aydin
Journal:  Scand J Infect Dis       Date:  1991

3.  [Role of penicillinase in the mechanism of resistance of Bacillus anthracis to benzylpenicillin].

Authors:  N P Buravtseva
Journal:  Antibiotiki       Date:  1971-02

Review 4.  Inhalational anthrax: epidemiology, diagnosis, and management.

Authors:  S Shafazand; R Doyle; S Ruoss; A Weinacker; T A Raffin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

5.  Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

Authors:  F A Abramova; L M Grinberg; O V Yampolskaya; D H Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 6.  The medical threat of biological weapons.

Authors:  R M Atlas
Journal:  Crit Rev Microbiol       Date:  1998       Impact factor: 7.624

7.  Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with Bacillus anthracis.

Authors:  T Sirisanthana; N Navachareon; P Tharavichitkul; V Sirisanthana; A E Brown
Journal:  Am J Trop Med Hyg       Date:  1984-01       Impact factor: 2.345

8.  A macrolide-lincosamide-streptogramin B resistance determinant from Bacillus anthracis 590: cloning and expression of ermJ.

Authors:  H S Kim; E C Choi; B K Kim
Journal:  J Gen Microbiol       Date:  1993-03

9.  The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park.

Authors:  M W Odendaal; P M Pieterson; V de Vos; A D Botha
Journal:  Onderstepoort J Vet Res       Date:  1991-03       Impact factor: 1.792

Review 10.  Bacillus cereus and related species.

Authors:  F A Drobniewski
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132
View more
  25 in total

1.  Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.

Authors:  Isabel C Materon; Anne Marie Queenan; Theresa M Koehler; Karen Bush; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

2.  Beta-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain.

Authors:  Yahua Chen; Fred C Tenover; Theresa M Koehler
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Antibiotic susceptibility and molecular diversity of Bacillus anthracis strains in Chad: detection of a new phylogenetic subgroup.

Authors:  Angaya Maho; Alexandra Rossano; Herbert Hächler; Anita Holzer; Esther Schelling; Jakob Zinsstag; Mahamat H Hassane; Bhen S Toguebaye; Ayayi J Akakpo; Matthew Van Ert; Paul Keim; Leo Kenefic; Joachim Frey; Vincent Perreten
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.

Authors:  L Mark Kao; Karen Bush; Roy Barnewall; James Estep; Frederic W Thalacker; Pamela H Olson; George L Drusano; Neil Minton; Shuchean Chien; Alex Hemeryck; Michael F Kelley
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

5.  Comprehensive Laboratory Evaluation of a Highly Specific Lateral Flow Assay for the Presumptive Identification of Bacillus anthracis Spores in Suspicious White Powders and Environmental Samples.

Authors:  Jason G Ramage; Kristin W Prentice; Lindsay DePalma; Kodumudi S Venkateswaran; Sruti Chivukula; Carol Chapman; Melissa Bell; Shomik Datta; Ajay Singh; Alex Hoffmaster; Jawad Sarwar; Nishanth Parameswaran; Mrinmayi Joshi; Nagarajan Thirunavkkarasu; Viswanathan Krishnan; Stephen Morse; Julie R Avila; Shashi Sharma; Peter L Estacio; Larry Stanker; David R Hodge; Segaran P Pillai
Journal:  Health Secur       Date:  2016 Sep-Oct

6.  In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.

Authors:  Esther W Barrow; Jürg Dreier; Stefan Reinelt; Philip C Bourne; William W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

7.  Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain.

Authors:  Yahua Chen; Janice Succi; Fred C Tenover; Theresa M Koehler
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

8.  Design and synthesis of aryl ether inhibitors of the Bacillus anthracis enoyl-ACP reductase.

Authors:  Suresh K Tipparaju; Debbie C Mulhearn; Gary M Klein; Yufeng Chen; Subhasish Tapadar; Molly H Bishop; Shuo Yang; Juan Chen; Mahmood Ghassemi; Bernard D Santarsiero; James L Cook; Mary Johlfs; Andrew D Mesecar; Michael E Johnson; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2008-08       Impact factor: 3.466

9.  MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest.

Authors:  Peter C B Turnbull; Nicky M Sirianni; Carlos I LeBron; Marian N Samaan; Felicia N Sutton; Anatalio E Reyes; Leonard F Peruski
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations.

Authors:  Patrick Grohs; Isabelle Podglajen; Laurent Gutmann
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.